Dorothea E. Roberts

Dori Roberts is a CMC Regulatory professional with over 25 years of experience in the pharmaceutical industry. She has held positions of increasing responsibility within CMC Regulatory Affairs at GSK, and has successfully supported a range of products throughout the development lifecycle. In her current role as Director, CMC Regulatory Affairs at GSK, she leads a team responsible for CMC Regulatory support of small molecule development compounds from first time in humans through early lifecycle. Additionally, Dori is currently the global CMC RA lead for a small molecule asset in late stage development, with continuous manufacturing processes for drug substance and drug product. Prior to roles in CMC Regulatory, Dori held roles in Analytical Chemistry in the Product Development functions at Pfizer and GSK. She holds a BS in Chemistry from the University of Delaware.